Revolution Medicines logo
Revolution Medicines RVMD
$ 56.76 -0.04%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Revolution Medicines EBITDA per Share 2011-2024 | RVMD

Annual EBITDA per Share Revolution Medicines

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.26 -3.15 -2.54 -1.97 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.97 -4.26 -2.98

Quarterly EBITDA per Share Revolution Medicines

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-1.04 -0.94 -0.85 - -1.12 -1.01 -0.78 - -0.89 -0.82 -0.77 - -0.69 -0.59 -0.52 - -0.39 -0.45 -0.7 - -4.23 -3.49 -3.75 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-0.39 -4.23 -1.28